You are in : Home » Results & submissions » Select UOA » 1 - Clinical Medicine » View submission: University of Plymouth » Outputs » Detail

Output details

1 - Clinical Medicine

University of Plymouth

Return to search Previous output Next output

Output 0 of 0 in the submission

Article title

Bortezomib plus rituximab versus rituximab alone in patients with relapsed, rituximab-naive or rituximab-sensitive, follicular lymphoma: a randomised phase 3 trial

Type

D - Journal article

DOI

10.1016/S1470-2045(11)70150-4

Title of journal

LANCET ONCOLOGY

Article number

Volume number

Issue number

First page of article

773

ISSN of journal

1470-2045

Year of publication

2011

URL

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000293272100028&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=11bb513d99f797142bcfeffcc58ea008

Number of additional authors

Additional information

The author made a substantial contribution to the conception and design of the study and carrying out the study (including acquisition of study). The author helped draft the output.

Interdisciplinary

Cross-referral requested

Research group

None

Citation count

Proposed double-weighted

Double-weighted statement

Reserve for a double-weighted output

Non-English

English abstract